EDNA MADAI MÉNDEZ-HERNÁNDEZ 1 , JESÚS HERNÁNDEZ-TINOCO 2 , JOSÉ MANUEL SALAS-PACHECO 3 , LUIS FRANCISCO SÁNCHEZ-ANGUIANO 3 , OSCAR ARIAS-CARRIÓN 4 , ADA AGUSTINA SANDOVAL-CARRILLO 3 , FRANCISCO XAVIER CASTELLANOS-JUÁREZ 3 , LUIS ÁNGEL RUANO-CALDERÓN 5 , COSME ALVARADO-ESQUIVEL 2 , *
02 July 2020
The link between Toxoplasma gondii infection and multiple sclerosis remains controversial. In the present study, we aimed to determine the association between T. gondii seropositivity and multiple sclerosis. Using an age- and gender-matched case-control study, we studied 45 patients who had multiple sclerosis attended in two public hospitals and 225 control subjects without this disease and other neurological disorders in Durango City, Mexico. Serum samples of cases and controls were analyzed for detection of anti -Toxoplasma IgG using a commercially available enzyme-linked immunoassay. One (2.22%) of the 45 patients with multiple sclerosis, and 15 (6.67%) of the 225 control subjects without this disease were seropositive for anti- T. gondii IgG antibodies. No statistically significant difference (OR = 0.31; 95% CI: 0.04–2.47; P = 0.48) in seroprevalence of anti- T. gondii IgG antibodies between cases and controls was found. The frequency of T. gondii seropositivity did not vary among cases and controls about sex or age groups. Results of this study do not support an association between seropositivity to T. gondii and multiple sclerosis. However, additional research with larger sample sizes to confirm this lack of association should be conducted.